#1Q4 2020 Earnings Presentation FMC An Agricultural Sciences Company February 10, 2021#2Safe Harbor Statement FMC An Agricultural Sciences Company 2 Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain statements made in this presentation are forward-looking statements. In some cases, you can identify these statements by such words or phrases as "will likely result," "is confident that," "expect," "expects," "should," "could," "may," "will continue to," "believe," "believes," "anticipates," "predicts," "forecasts," "estimates,” “projects,” “potential," "intends" or similar expressions identifying "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words and phrases. Such forward-looking statements are based on management's current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. Currently, one of the most significant factors is the potential adverse effect of the current COVID-19 pandemic on the financial condition, results of operations, cash flows and performance of FMC, which is substantially influenced by the potential adverse effect of the pandemic on FMC's customers and suppliers and the global economy and financial markets. The extent to which COVID-19 impacts us will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the scope, severity and duration of the pandemic, the actions taken to contain the pandemic or mitigate its impact, and the direct and indirect economic effects of the pandemic and containment measures, among others. Additional factors include, among other things, the risk factors and other cautionary statements included within FMC's 2019 Form 10-K and FMC's Form 10-Q for the quarter ended September 30, 2020, as well as other SEC filings and public communications. Moreover, investors are cautioned to interpret many of these factors as being heightened as a result of the ongoing and numerous adverse impacts of the COVID-19 pandemic. FMC cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Forward-looking statements are qualified in their entirety by the above cautionary statement. FMC undertakes no obligation, and specifically disclaims any duty, to update or revise any forward-looking statements to reflect events or circumstances arising after the date on which they were made, except as otherwise required by law. Non-GAAP Financial Terms These slides contain certain "non-GAAP financial terms". Such non-GAAP financial terms include adjusted EBITDA, adjusted EPS, adjusted tax rate, adjusted cash from operations, free cash flow ("FCF") and organic revenue growth. Definitions of these terms, as well as a reconciliation to the most directly comparable financial measure calculated and presented in accordance with GAAP, are provided on our website investors.fmc.com. Although we provide forecasts for these non-GAAP financial measures, we are not able to forecast the most directly comparable measures calculated and presented in accordance with GAAP. Certain elements of the composition of the GAAP amounts are not predictable, making it impractical for us to forecast. Such elements include, but are not limited to restructuring, acquisition charges, and discontinued operations and related cash activity. As a result, no GAAP outlook is provided.#3FMC Reported Financial Results FMC An Agricultural Sciences Company Q4 2019 Q4 2020 '20 vs. '19 Revenue $1,197 $1,152 -4% GAAP Net Income ($3) $47 N/A % Revenue -0.2% 4.1% GAAP EPS ($0.02) $0.38 N/A Adj. EBITDA 1 $320 $290 -9% Q4 Highlights 2% organic revenue growth', excluding a 5% FX headwind Strong growth in EMEA & Asia North America disruptions, LatAm drought and Argentina customs delay impacted revenue Adj. EPS1 vs. Q4 2019 % Revenue 26.7% 25.2% Adjusted EPS 1 $1.76 $1.42 -19% Q4 '20 Adj. EPS¹ -34 cents vs. Q4 '19 YOY EBITDA -22 cents Note: Amounts in millions of USD, except EPS D&A -2 cents Interest Expense +6 cents Tax Rate -18 cents Non-contr. Interest +2 cents 3 (1) Denotes non-GAAP financial term. Refer to non-GAAP financial terms at the beginning of this presentation.#4Q4 2020 Revenue Down 4%, Up 2% Organically $1,197 Regional Revenue Bridge $66 $29 ($47) $1,152 ($93) Q4'19 EMEA Asia LatAm NA Q4'20 Note: Amounts in millions of USD Q4 2020 Revenue Drivers EMEA ■ Q4 '20 Revenue: $213 mil. (+45% YOY, +42% ex-FX) Very strong diamide growth on specialty crops Early orders in UK ahead of Brexit Herbicides strong on cereals in France, Spain, Russia and Germany Latin America ■ Q4 '20 Revenue: $471 mil. (-9% YOY, +4% ex-FX) ■ Brazil drought delayed season, fewer sprays in shortened season ■ Growth in Argentina despite customs delay of product FMC An Agricultural Sciences Company Asia ■ Q4 '20 Revenue: $288 mil. (+11% YOY, +11% ex-FX) ■ Over 25% organic growth in - India strong in rice, pulses, sugarcane China, Japan and Australia posted over 20% growth ■ Diamide growth strong across the region North America ■ Q4 '20 Revenue: $181 mil. (-34% YOY) Supply chain and logistics disruptions, related to COVID- 19 pandemic ■ Reduced demand for certain pre-emergent herbidices Total: -4% Organic¹: +2%2 Volume -3% Price F/X +4% -5% ■ Cotton acreage decline 4 (1) Denotes non-GAAP financial term. Refer to non-GAAP financial terms at the beginning of this presentation. (2) Factors do not sum to +2% organic growth due to rounding.#55 Q4 2020 Adj. EBITDA Decreased 9% FMC An Agricultural Sciences Company Q4 2020 Adj. EBITDA Bridge $320 ($2) $50 ($3) ($75) $290 Q4'19 Volume Price Cost F/X Q4'20 Q4 2020 Adj. EBITDA Drivers EBITDA $30 million below a strong Q4 2019, mainly driven by FX headwinds Price increases offset significant amount of FX headwinds Volume lower than expected in North America and Latin America Aggressive cost controls versus prior expectations Note: Amounts in millions of USD (1) Denotes non-GAAP financial term. Refer to non-GAAP financial terms at the beginning of this presentation.#6Full-Year 2020 Financial Results FMC An Agricultural Sciences Company 2019 2020 '20 vs. '19 • Revenue $4,610 $4,642 1% GAAP Net Income $480 $551 15% % Revenue 10.4% 11.9% FY 2020 Highlights 7% organic revenue growth, excluding a 6% FX headwind Adj. EBITDA margins increased 40 bps YOY GAAP EPS $3.62 $4.22 17% Adj. EBITDA 1 $1,221 $1,250 2% EPS vs. 2019 FY 2020 Adj. EPS¹ +10 cents* vs. FY 2019 YOY % Revenue 26.5% 26.9% EBITDA +20 cents Adjusted EPS $6.09 $6.19 2% D&A -9 cents Interest Expense +5 cents Note: Amounts in millions of USD, except EPS Tax Rate -15 cents Non-contr. Interest +3 cents Share Count +7 cents 6 (1) Denotes non-GAAP financial term. Refer to non-GAAP financial terms at the beginning of this presentation. * Factors do not sum to 10 cents, due to rounding#77 Full-Year 2020 Revenue Up 1%, Up 7% Organically Regional Revenue Bridge FMC An Agricultural Sciences Company $62 $45 $15 $4,610 $4,642 ($89) 2019 Asia EMEA LatAm NA 2020* Note: Amounts in millions of USD FY 2020 Revenue Drivers Total: +1% Organic¹: +7% Volume +4% Price F/X +3% -6% Asia ■ 2020 Revenue: $1.1 billion (+6% YOY, +9% ex-FX) Double-digit organic growth in India and Pakistan driven by share gain ■ Australia +20% organic growth from market recovery ■Diamide growth strong across the region Latin America ■ 2020 Revenue: $1.5 billion (+1% YOY, +17% ex-FX) High-single digit volume growth driven by Brazil and Argentina Strong demand on soybeans and sugarcane ■ Cotton acreage decline in 2020/2021 season (1) Denotes non-GAAP financial term. Refer to non-GAAP financial terms at the beginning of this presentation. Factors do not sum to $4,642 million, due to rounding. EMEA ■ 2020 Revenue: $1.0 billion (+4% YOY, +6% ex-FX) ■ Diamides and other insecticides strong on specialty crops, herbicides growth on cereals/ potatoes ■ New products drove 2% growth to partially offset registration losses North America ■ 2020 Revenue: $1.0 billion (-8% YOY) ■ Proactive channel inventory drawdowns in H1 of Authority herbicides Strong second year for LucentoⓇ fungicide launch Supply chain and logistics disruptions in Q4#8FY 2020 Adj. EBITDA Increased 2% FMC An Agricultural Sciences Company $1,221 FY 2020 Adj. EBITDA Bridge $111 $118 $70 ($269) $1,250 FY 2020 Adj. EBITDA Drivers Adj. EBITDA growth despite $269M in FX headwinds Strong volume contribution, led by LatAm and Asia Aggressive cost management throughout year Pricing offset about 45% of FX headwinds 2019 Volume Price Cost F/X 2020* Note: Amounts in millions of USD (1) Denotes non-GAAP financial term. Refer to non-GAAP financial terms at the beginning of this presentation. 8 * Factors do not sum to $1,250 million, due to rounding.#99 2021 Global AgChem Market Projected to Grow Low-Single Digits North America Market - Up Low-Single Digits ■ U.S.: Strong commodity prices and acre recovery support grower volumes for row crop products. Distributors and retailers signal a strategic reduction of inventory levels. Specialty crop market projected stable; demand to be determined by pace of economic recovery. ■ Canada: Outlook for commodity prices trending positive. Some specialty crop acre growth. Latin America Market - Up Low-Single Digits ■ Brazil: Slow recovery from pandemic. Expectation of more stable exchange rate. Market projected to recover AgChem price losses from 2020. Positive commodities scenario and profitability on key crops expected to help demand on the field. Argentina: Higher soybean area, lower corn area. ■ Mexico: Increase in F&V exports. Strong F&V crop prices leading to increasing on-the-ground demand for high-value CP products. FMC An Agricultural Sciences Company EMEA Market - Up Low-Single Digits ■ Western EUR: Positive commodity prices to drive higher CP use. Specialty crop demand recovery post-COVID. UK, Baltics: Partial recovery versus 2020 market decline, due to improved weather and crop conditions. ■ Eastern EUR: Partial recovery from dry conditions seen in 2020 in cereals, corn, and OSR. ■ Middle East & Africa: Partial recovery of cotton area and normal pest pressure projected. Asia Market - Up Low- to Mid-Single Digits ■ India: Good rains supporting the Rabi season (Q4-Q1), major Kharif season to be normal (Q3). Reduced issues with COVID. ▪ Australia/ASEAN: Strong market conditions in Australia. La Nina projected in Q1, above normal rainfall. ■ China: Crop area stable and produce consumption expected to improve. Reduced issues with COVID. ■ North Asia: Market projected stable, Japan & South Korea rice planting area continuing to decline due to lower consumption.#10FY 2021 and Q1 Earnings Outlook FMC An Agricultural Sciences Company FY 2021 Q1 2021 $6.65-$7.35 $1.40 $1.60 Adjusted EPS Ranges (1,2) +13% YOY at midpoint -18% YOY at midpoint WADSO: 131 million WADSO: ~131 million Revenue & Adjusted EBITDA (1) Ranges Revenue: $4.9 $5.1 billion Adj. EBITDA: $1.32 - $1.42 billion Revenue +8% YOY at midpoint (+9% organic) Adj. EBITDA growth of +10% YOY at midpoint Revenue: $1.13 - $1.20 billion Adj. EBITDA: $290 - $320 million Revenue -7% YOY at midpoint (-5% organic) Adj. EBITDA change of -15% YOY at midpoint 10 10 (1) Denotes non-GAAP financial term. Refer to non-GAAP financial terms at the beginning of this presentation. (2) Outlook for EPS and weighted average diluted shares outstanding (WADSO) does not include the impact of any 2021 share repurchases.#1111 Projected FY 2021 Adj. EBITDA and Revenue Drivers (YOY) FY 2021 Adj. EBITDA Bridge FMC An Agricultural Sciences Company $1,250 $140 $70 ($90) $0 50 $1,370 FY 2021 Adj. EBITDA Drivers Volume growth led by Asia, improved weather in LatAm / EMEA, new products, strong soybean fundamentals Price increases continue to recoup 2020 FX headwind Cost headwinds from R&D, some reversal of 2020 cost reductions and supply chain cost increases FY 2021 Revenue Drivers 2020 Volume Price Cost F/X 2021G* Note: Amounts in millions of USD Total: +8% Organic¹: +9% Volume Price F/X +7% +2% -1% * Midpoint of guidance (1) Denotes non-GAAP financial term. Refer to non-GAAP financial terms at the beginning of this presentation.#1212 Projected Q1 2021 Adj. EBITDA' and Revenue Drivers (YOY) $357 Q1 2021 Adj. EBITDA Bridge ($40) $15 ($12) ($15) $305 FMC An Agricultural Sciences Company Q1 2021 Adj. EBITDA Drivers Volume down due to Brazil cotton acreage decline, discontinued registrations in EMEA and Brexit pre-order timing Price increases expected to offset F/X headwind Cost headwind driven by R&D investments Q1 2021 Revenue Drivers Q1'20 Volume Price Cost F/X Q1'21G* Note: Amounts in millions of USD Total: -7% Organic¹: -5% Volume Price F/X -6% +1% -2% * Midpoint of guidance (1) Denotes non-GAAP financial term. Refer to non-GAAP financial terms at the beginning of this presentation.#13Q4/2020 Cash Flow Results and 2021 Cash Flow Outlook FMC An Agricultural Sciences Company ($ in millions) Q4 '19 Q4'20 % Chg.³ 3 2019 2020 3 % Chg. 2021 Outlook % Chg.³ 3 Adjusted Cash from Operations $505 $434 -14% $633 $801 27% $790 - $950 9% Capital Additions and Other Investing Activities ($70) ($29) -58% ($148) ($88) -41% ($160) - ($200) 105% Legacy and Transformation 2 ($53) ($8) -84% ($183) ($169) -8% ($100) - ($130) -32% 1 FCF (before dividends, repurchases and M&A) $383 $396 4% $302 $544 80% $530 - $620 6% 2020 Cash Drivers 3 Adj. cash from operations up $168 million: Growth in working capital more than offset by lower change in other assets/liabilities, lower cash taxes, and increased EBITDA Capital additions down $60 million: COVID-driven project delays/deferrals result in lower spend Legacy and transformation down $14 million: Completed SAP program on schedule and below 2020 budget (1) Denotes non-GAAP financial term. Refer to non-GAAP financial terms at the beginning of this presentation. (2) 13 (3) (4) 2021 Outlook 4 Adj. cash from operations up $69 million: Higher EBITDA and working capital improvement partially offset by increases in non-working capital items Capital additions up $92 million: Catch up on deferred projects, capacity growth Legacy and transformation down $54 million: Completion of SAP program partially offset by higher Legacy items Legacy Liabilities include liabilities from discontinued operations, net of legacy liabilities from continuing operations that are already captured in Adjusted Cash from Operations. Transformation costs include SAP implementation, DuPont Integration and Livent Separation. These amounts / percentages are calculated using the amounts shown in the Financial Schedules that accompany our earnings release. Relative changes noted here are based on midpoint of guidance ranges in the table above.#1414 Free Cash Flow ($M) 1 Normalized FCF Shows Growth, On Track to Deliver 5-Year Plan Normalized FCF Trend (2018 – 2023) FMC An Agricultural Sciences Company $1,000 90% 80% 65% 70% $750 62% 60% ~$600 50% ~$500 $500 38% 40% 30% $250 18% 20% 10% 0% 2018 2019 2020T* 2021GT** 2022 2023² (1) Denotes non-GAAP financial term. Refer to non-GAAP financial terms at the beginning of this presentation. Λ Recast 2018 excludes the former Lithium segment. * 2020T accounts for certain timing factors that increased FCF by ~$44 million. ** 2021GT starts with the midpoint of guidance and accounts for certain timing factors that decrease FCF by ~$25 million. (2) Implied 2023 FCF at targeted 7% -9% CAGR for EBITDA through 2023. FCF Conversion Normalization Factors Real estate asset sale in 2020 will not repeat ($24 million, net of tax) Lump sum payment for environmental liability was expected to occur in Q4 2020 and was delayed to Q1 2021 ($21 million shift) Other 2020-21 Factors Transformation spending expected to decline substantially in 2021 with completion of SAP implementation Capital additions abnormally low in 2020, returning to more normal levels in 2021#15Disciplined, Balanced Cash Deployment Cash Deployment (2019 - 2021) FMC An Agricultural Sciences Company $800 $700 $610 $600 $500 $400 $300 $200 $100 $0 $343 -$700+ 2019 2020 2021G* Share Repurchases ■Dividends ■Inorganic Growth Investments^ Note: Amounts in millions of USD Λ Inorganic growth investment in 2020 was $65 million acquisition of remaining Fluindapyr assets from Isagro. 15 * Includes the midpoint of guidance range for share repurchases. 2021 Highlights Share repurchases of $400 to $500 million expected in 2021, starting in Q1 Dividend increased 9% in December 2020 No estimate for inorganic growth investments Total cash to be deployed in 2021 is expected to be ~$700 million or higher#1616 Appendix Other Financial Items FMC An Agricultural Sciences Company Interest Expense Adjusted Tax Rate (1) Non-Controlling Interest Full-Year Weighted Avg. Diluted Shares Outstanding (WADSO) (2 Depreciation & Amortization Free Cash Flow (1) $130 $140 million 12.5 14.5 percent - ~$4 million ~131 million $165 $175 million - Capital Additions and Other Investing Activities $530 $620 million $160 $200 million (1) Denotes non-GAAP financial term. Refer to non-GAAP financial terms at the beginning of this presentation. (2) Planned share repurchases for 2021 are not factored into estimate for FMC weighted average diluted shares outstanding (WADSO).#1717 2020 Appendix Regional Growth FMC An Agricultural Sciences Company FMC Q4 % Chg FMC H2 % Chg FMC 2020 % Chg % Chg % Chg % Chg Sales ex-FX Sales ex-FX Sales ex-FX NA $181 -34% -34% $393 -16% -16% $1,033 -8% -8% LatAm $471 -9% 4% $936 -4% 11% $1,457 1% 17% EMEA $213 45% 42% $366 28% 26% $1,046 4% 6% Asia $288 11% 11% $542 13% 15% $1,107 6% 9% Total $1,152 -4% 2% $2,237 1% 8% $4,642 1% 7% Note: Amounts in millions of USD